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Pseudomonas aeruginosa b-lactamase induction
requires two permeases, AmpG and AmpP
Kok-Fai Kong1*, Alian Aguila1, Lisa Schneper2, Kalai Mathee2*
Abstract
Background: In Enterobacteriaceae, b-lactam antibiotic resistance involves murein recycling intermediates. Murein
recycling is a complex process with discrete steps taking place in the periplasm and the cytoplasm. The AmpG
permease is critical to this process as it transports N-acetylglucosamine anhydrous N-acetylmuramyl peptides across
the inner membrane. In Pseudomonadaceae, this intrinsic mechanism remains to be elucidated. Since the
mechanism involves two cellular compartments, the characterization of transporters is crucial to establish the link.
Results: Pseudomonas aeruginosa PAO1 has two ampG paralogs, PA4218 (ampP) and PA4393 (ampG). Topology
analysis using b-galactosidase and alkaline phosphatase fusions indicates ampP and ampG encode proteins which
possess 10 and 14 transmembrane helices, respectively, that could potentially transport substrates. Both ampP and
ampG are required for maximum expression of b-lactamase, but complementation and kinetic experiments suggest
they act independently to play different roles. Mutation of ampG affects resistance to a subset of b-lactam
antibiotics. Low-levels of b-lactamase induction occur independently of either ampP or ampG. Both ampG and
ampP are the second members of two independent two-gene operons. Analysis of the ampG and ampP operon
expression using b-galactosidase transcriptional fusions showed that in PAO1, ampG operon expression is b-lactam
and ampR-independent, while ampP operon expression is b-lactam and ampR-dependent. b-lactam-dependent
expression of the ampP operon and independent expression of the ampG operon is also dependent upon ampP.
Conclusions: In P. aeruginosa, b-lactamase induction occurs in at least three ways, induction at low b-lactam
concentrations by an as yet uncharacterized pathway, at intermediate concentrations by an ampP and ampG
dependent pathway, and at high concentrations where although both ampP and ampG play a role, ampG may be
of greater importance. Both ampP and ampG are required for maximum induction. Similar to ampC, ampP
expression is inducible in an ampR-dependent manner. Importantly, ampP expression is autoregulated and ampP
also regulates expression of ampG. Both AmpG and AmpP have topologies consistent with functions in transport.
Together, these data suggest that the mechanism of b-lactam resistance of P. aeruginosa is distinct from well
characterized systems in Enterobacteriaceae and involves a highly complicated interaction between these putative
permeases and known Amp proteins.
Background
Pseudomonas aeruginosa is a Gram negative opportunis-
tic pathogen. As a frequent colonizer of catheters and
the most frequent fatal causative agent of ventilator-
assisted pneumonia, it is one of the most common
agents in health-care associated infection [1]. Lung
deterioration due to chronic infection by P. aeruginosa
affects patients with chronic obstructive pulmonary dis-
order and is a leading cause of morbidity and mortality
in cystic fibrosis patients [2]. P. aeruginosa infection
treatment is often difficult because of the organism’s
intrinsic and acquired antibiotic resistance. This is due
to the presence of multidrug efflux pumps [3], low outer
membrane permeability [4], hypermutability [5], biofilm
formation [6], and b-lactamase expression [7,8].
P. aeruginosa has two chromosomally encoded
b-lactamases: the PoxB oxacillinase and the AmpC
cephalosporinase [8-10]. Much of what is known about
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AmpC regulation is from studies in Escherichia coli,
Citrobacter freundii and Enterobacter cloacae. These
studies have elegantly demonstrated that induction of
AmpC, the chromosomal b-lactamase, involves ampR,
ampD, and ampG, encoding a LysR type transcriptional
factor, an amidase, and a permease, respectively [11].
Expression of C. freundi AmpR in E. coli revealed
that during normal physiological growth, AmpR, in the
presence of UDP-MurNAc-peptide, binds to the ampC
promoter and inhibits expression [12]. In E. coli, the
addition of b-lactam antibiotics causes an increase in
the cytosolic 1,6-anhydro-N-acetylmuramyl-L-Ala-
g-D-Glu-meso-diaminopimelic acid (anhMurNAc-tri-
peptide) concentration, and a decrease in the cytosolic
UDP-N-acetylmuramyl-L-Ala-g-D-Glu-meso-DAP-
D-Ala-D-Ala (UDP-MurNAc-pentapeptide) [12]. It was
postulated that AmpR can either activate or repress
transcription from the ampC promoter and that its
activity is dependent upon the nature of the bound
effector molecule. In vitro, in the presence of UDP-
MurNAc-pentapeptide, AmpR represses transcription
of ampC, whereas in the presence of 1,6-anhMurNAc-
tripeptide, AmpR activates ampC [12]. Thus, it is pos-
tulated that binding of 1,6-anhMurNAc-tripeptide
alters the conformation of AmpR from the repressive
to the activating mode, facilitating the expression of
ampC [12]. High-levels of 1,6-anhMurNAc-tripeptide
accumulate in the absence of ampD. AmpD is an ami-
dase that cleaves 1,6-anhMurNAc-tripeptide [13].
Induction of E. cloacae ampC was also shown to be
ampG-dependent [14]. b-lactamase fusion analysis
suggests that E. coli AmpG contains 10 transmembrane
segments and two large cytoplasmic loops [15]. E. coli
AmpG was shown to transport N-acetylglucosamine-
anhydrous N-acetylmuramic acid (GlcNAc-anhMurNAc)
and GlcNAc-anhMurNAc-tri, -tetra, and -pentapeptides
[16,17].
Comprehensive and elegant studies using Enterobac-
teriaceae established the paradigm of the b-lactamase
induction mechanism. Orthologs of ampR, ampD, and
ampG are found in numerous Gram-negative species
[18]. Whether similar mechanisms are employed in all
these organisms has not been established. It is possible
that the induction mechanism could differ. The b-lacta-
mase induction mechanism of P. aeruginosa has not
been well-defined; however, it is known that P. aerugi-
nosa AmpR regulates expression of ampC as in other
organisms [8-10]. Similar to other systems, ampR is
located upstream of the ampC gene [10]. Additionally,
P. aeruginosa AmpR controls transcription of the oxa-
cillinase, poxB, and several genes involved in virulence
[8-10]. Loss of AmpR in P. aeruginosa causes a signifi-
cant elevation in b-lactamase activity and other viru-
lence factors [10]. P. aeruginosa also differs from other
previously studied systems in that its genome has two
ampG orthologs, PA4218 and PA4393 [19]. The current
study reveals that these two genes, PA4218 and PA4393,
are required for b-lactamase induction, hence they have
been named ampP and ampG, respectively. Consistent
with their putative roles as permeases, fusion analysis
suggests that AmpG and AmpP have 14 and 10 trans-
membrane helices, respectively. Expression of ampP is
dependent upon AmpR and is autoregulated. Together,
these data suggest the distinctiveness of P. aeruginosa
b-lactamase induction, as it is the first system that
potentially involves two permease paralogs, and contri-
bute to the general understanding of the induction
mechanism.
Results
Genome Sequence Analysis of the PA4218 and PA4393
Operons
E. coli AmpG has been shown to be a permease that
transports GlcNAc-anhMurNAc peptides from the peri-
plasm to the cytoplasm [13,17]; however, the AmpG func-
tion in P. aeruginosa has not been described. BLAST
analysis of the E. coli AmpG sequence against the six-
frame translation of the PAO1 genome identified two
open reading frames, PA4218 and PA4393, with significant
homology [20,21]. Global alignment using the Needleman-
Wusch algorithm [22] demonstrated that PA4218 is 21.8%
identical and 34.8% similar, while PA4393 is 23.2% identi-
cal and 34.3% similar to AmpG (Figure 1). The Pseudomo-
nas Genome Database identifies PA4393 as encoding a
putative permease with an alternate name of ampG, while
PA4218 is identified as encoding a probable transporter
[23]. Thus, PA4393 will be referred to as ampG and
PA4218 as ampP (P for permease).
Analysis of the sequences around ampG and ampP
revealed that they were in close proximity to two
respective upstream ORFs. Based upon sequence analy-
sis, it is likely that ampG and ampP constitute two two-
gene operons with their respective upstream ORFs
(Figures 2A and 2B). PA4219 (ampO) overlaps the first
seven base pairs of ampP (Figure 2A). AmpO is a puta-
tive seven-transmembrane protein with a strong lipopro-
tein signal peptide that has a potential cleavage site
between amino acids 18 and 19 [23]. The ampG gene is
located 43 bp downstream from PA4392 (ampF), which
encodes a putative protein with a DNA-protein cysteine
methyltransferase domain (Figure 2B). The function of
this domain remains unknown. No lipoprotein signal
was detected in AmpF.
To determine if ampG and ampP constitute two-gene
operons with their upstream ORFs, RNA isolated from
PAO1 was analyzed by reverse transcription polymerase
chain reaction (PCR) using primers flanking the inter-
genic (ampF-ampG) (Figure 3A) and the overlapping
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(ampO-ampP) region (Figure 3B). The expected ampli-
con sizes are 136 and 158 bp for the ampF-G junction
and ampO-P junction, respectively [23]. As expected,
amplification was observed with genomic DNA
(Figures 3A and 3B, Lane 3). In the RNA analyses,
PCR products were observed in reverse transcription
PCR when the template was prepared in the presence
of reverse transcriptase (Figures 3A and 3B, Lane 1),
but not in the control reaction when reverse transcrip-
tase was omitted (Figures 3A and 3B, Lane 2). This
confirms that ampO and ampP constitute a two-gene
operon and ampF and ampG constitute another. In
addition, reverse transcriptase real time PCR data is in
agreement with ampO and ampP belonging to the
same operon and ampF and ampG comprising another
operon (data not shown).
Topology analysis of AmpG and AmpP
The ampG and ampP genes encode predicted proteins
with 594 and 414 amino acids, isoelectric points of 9.3
and 9.4, and calculated molecular weights of 64.6 kDa
and 43.2 kDa, respectively. Hydrophobicity plots pre-
dict that AmpG has 16 or 14 predicted transmembrane
(TM) helices, depending upon the algorithm used and
AmpP has 10 [23]. To determine the membrane topol-
ogy of AmpG and AmpP, phoA or lacZ was cloned
downstream of the ampG and ampP genes. The 3’-end
of the ampG and ampP genes were progressively
deleted using exonuclease III. At various time-points,
the truncated genes were ligated and assayed for PhoA
and LacZ activities in E. coli. Clones were also
sequenced to determine the reporter and amp gene
junctions.
Figure 1 Alignment of E. coli AmpG, PA4218 and PA4393. The primary sequence of E. coli AmpG, PA4218 (AmpP) and PA4393 (AmpG) were
used as an input to M-Coffee, which combines multiple sequence alignments using the T-Coffee platform [45,46]. Identical and similar amino
acids were shaded black and gray, respectively, using BOXSHADE.
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AmpG fusions at amino acids 80, 146, 221, 290, 368,
438, 468, 495, as well as full length were LacZ-positive
and PhoA-negative, and fusions at amino acids 51, 185,
255, 338, 406, and 540 were PhoA-positive and LacZ-
negative domains, suggesting that AmpG has only 14
TM helices (Figures 4C and 4D). AmpP fusions at
amino acids 80, 170, 248, 308, 400 as well as full length
were LacZ-positive and PhoA-negative, and fusions at
amino acids 38, 120, 195, 278, and 360 were LacZ-nega-
tive and PhoA-positive, consistent with 10 TM domains
(Figures 4A and 4B).
b-lactamase activity in strains containing mutations in
ampG and ampP
The failure to induce C. freundii ampC in the absence
of E. coli ampG suggested that AmpG is essential for
Figure 2 Physical map of the ampO-ampP (A) and ampF-ampG (B) loci. The restriction map is based on PAO1 genome sequence with
relevant restriction sites. (A) The 2779-bp ampO-ampP fragment has the PAO1 coordinates of 4721496 to 4724275. (B) The 2904-bp ampF-ampG
fragment corresponds to the PAO1 coordinates of 4921591 to 4924494. The plasmids pKKF03 and pKKF04 are derivatives of pCRII-TOPO
(Invitrogen, CA), whereas pKKF157 and pKKF161 are derivatives of pME6030 [41]. The Gm cassette (black inverted triangle) was inserted into the
HincII and AscI sites of pKKF03 and pKKF04, respectively.
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Figure 3 PCR analysis of ampFG and ampOP operon cDNA. Polyacrylamide gel electrophoresis of PCR products of the junctions of the
ampOP and ampFG operons. (A) PCR with primers PA4392_3junctionRTF and PA4392_3junctionRTR to amplify the PA4392 - PA4393 intergenic
region. (B) PCR with primers PA4218_9junctionRTF and PA4218_9junctionRTR to amplify the PA4392 - PA4393 intergenic region. (Panels A and B)
Lane M: PCR markers (Promega, Madison, WI). Lane 1, cDNA reaction performed with PAO1 RNA, the appropriate buffer and Superscript RT III.
Lane 2, cDNA reaction performed with PAO1 RNA, the appropriate buffer without Superscript RT III. Lane 3, P. aeruginosa genomic DNA. The
asterisk indicates a nonspecific product. Arrows indicate junction amplicons.
Figure 4 Topology of AmpP and AmpG. The topology of AmpP and AmpG was analyzed by in-frame ampP and ampG fusions to the lacZ
and phoA genes, the cytoplasmic and periplasmic markers, respectively. The corresponding points of fusion and qualitative biochemical results
of the b-galactosidase (LacZ) and alkaline phosphatase (PhoA) assays [44] are shown for AmpP (A) and AmpG (C). These results, together with
transmembrane domain predictions generated using a Kyte-Doolittle algorithm present in Lasergene 7 (DNASTAR, Madison, WI) were used to
predict the topology of AmpP (B) and AmpG (D). Solid lines indicate prediction based upon experimental data, dashed lines indicate regions
where more than one possibility exists. Cytoplasm and periplasm are denoted by Cyto and Peri, respectively. Fusion sites are indicated by a dot
with the corresponding amino acid number. Putative transmembrane domain boundaries were obtained from Lasergene.
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the induction of chromosomal b-lactamases [24,25]. To
ascertain the role of the permeases in P. aeruginosa, iso-
genic ampG and ampP insertional inactivation mutants
were constructed in the prototypic P. aeruginosa strain
PAO1, referred to as PAOampG and PAOampP, respec-
tively. The b-lactamase activity in the two isogenic
mutants, PAOampG and PAOampP, was compared to
PAO1. In the absence of b-lactam antibiotics, all strains
showed a basal level of b-lactamase activity (Table 1).
Upon challenge with 500 μg/ml of benzyl-penicillin, this
level was elevated 10-fold (p < 0.05) in PAO1 (Table 1).
However, the b-lactamase activities of PAOampP and
PAOampG remained low in the presence of b-lactam
antibiotic, indicating a loss of b-lactamase induction
(Table 1). The loss of inducibility in PAOampG could
be partially restored by expressing ampG in trans,
whereas the b-lactamase inducibility of PAOampP was
completely recovered when ampP was supplied in trans
(Table 1). Both PAOampP and PAOampG mutants had
the other copy of the permease gene intact. These
observations suggest that ampG and ampP are individu-
ally important members of the b-lactamase induction
system. To confirm that ampG and ampP play indepen-
dent roles, cross-complementation of PAOampP with
pAmpG, and PAOampG with pAmpP was performed.
Similar to the mutants, the cross-complemented strains
did not show inducible b-lactamase activity (Table 1).
To further understand the role of ampG and ampP in
b-lactamase induction, b-lactamase activity was assayed
at different concentrations of benzyl-penicillin in PAO1,
PAOampG and PAOampP (Figure 5). Upon encounter
with the inducer (25 μg/ml), there was approximately
38% induction (Figure 5). For strain PAO1, this increase
in b-lactamase activity continued in a dose-dependent
manner until the maximum level of b-lactamase activity
was reached when 100 μg/ml of benzyl-penicillin was
added (Figure 5). A higher concentration of inducer did
not result in a concomitant increase in the expression of
the b-lactamase (Figure 5 and data not shown).
In PAOampG, the initial increase of b-lactamase
activity was observed at 25 μg/ml, suggesting that this
burst of b-lactamase production is ampG-independent
(Figure 5). However, unlike PAO1, the induction level
failed to increase after 25 μg/ml of benzyl-penicillin and
even significantly decreased with addition of increased
concentrations of benzyl-penicillin (Figure 5).
Mutation of ampP also prevented maximum induction
of b-lactamase, but the defect was not quite as severe as
in PAOampG. In PAOampP, the pattern of b-lactamase
induction was very similar to PAO1 at concentrations of
benzyl-penicillin up to 50 μg/ml (Figure 5). However,
unlike PAO1, addition of benzyl-penicillin at concentra-
tions greater than 50 μg/ml failed to further induce
production of b-lactamases (Figure 5). Thus, low induc-
tion is independent of ampG or ampP. The observation
that PAOampP exhibited higher levels of b-lactamase
expression at higher concentrations of benzyl-penicillin
may suggest that ampG plays a greater role at higher
concentrations of b-lactam.
Most of the b-lactamase activity of P. aeruginosa can
be attributed to AmpC, however, P. aeruginosa does
contain another chromosomally encoded b-lactamase,
PoxB [9,26]. To further analyze if the loss of b-lacta-
mase induction in the PAOampG and PAOampP strains
was due to loss of AmpC function, the ampC promoter
(PampC) activity was measured in PAO1, PAOampG, and
PAOampP. As expected, upon treatment with benzyl-
penicillin, PampC-lacZ activity increased approximately
15-fold (Figure 6). Benzyl-penicillin dependent induction
of PampC-lacZ was lost in PAOampG or PAOampP
(Figure 6).
To further characterize the role of ampG and ampP,
the sensitivity of PAO1, PAOampG, and PAOampP to
several b-lactams was determined (Table 2 and data not
Table 1 b-lactamase activity of P. aeruginosa PAO1, PAOampG and PAOampP in the absence and presence of b-lactam
Strain and plasmid Relevant genotypes (supplement in trans) b-lactamase activitya
Uninduced Inducedb
PAO1 ampG+ampP+ 22.2 ± 9.7 221.4c ± 9.2
PAOampG ampG-ampP+ 20.4 ± 6.2 28.8d ± 3.3
PAOampP ampG+ampP- 4.2 ± 6.2 32.2d ± 3.3
PAOampG/pKKF69 ampG-ampP+ (ampG+) 8.4 ± 1.4 87.6 ± 14.4
PAOampP/pKKF73 ampG+ampP- (ampP+) 8.8 ± 1.8 217.9 ± 35.5
PAOampG/pKKF73 ampG-ampP+ (ampP+) 2.1 ± 2.0 14.4 ± 1.9
PAOampP/pKKF69 ampG+ampP- (ampG+) 5.3 ± 1.9 10.6 ± 2.7
a Cultures at OD600 of 0.6-0.8 were divided in two. One set was induced with 500 μg/ml benzyl-penicillin for three hours before harvesting. Assays were
performed on sonicated lysate using nitrocefin as a chromogenic substrate. One milliunit of b-lactamase is defined as 1 nanomole of nitrocefin hydrolyzed per
minute per microgram of protein. Assays were performed in triplicate.
b Induction was carried out using 500 μg/ml benzyl-penicillin.
c p < 0.05 compared to uninduced PAO1.
d p < 0.05 compared to induced PAO1.
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shown). Inactivation of ampG led to a significant
decrease in resistance to amoxicillin (> 16-fold) and imi-
penem (> seven-fold). No difference was observed with
ampicillin/sulbactam, cefaclor, cefepime, oxacillin, piper-
acillin, piperacillin/tazobactam, or ticaricillin/clavulonic
acid (data not shown). Inactivation of ampP in PAO1
did not alter its resistance profile with these b-lactams
(Table 2 and data not shown).
AmpR regulation of PampFG and PampOP
In inducible amp systems, the expression of ampC is
tightly regulated by the transcription factor, AmpR [27].
In order to investigate the role, if any, of AmpR in the
regulation of P. aeruginosa ampG and ampP, PampFG-
lacZ and PampOP-lacZ promoter fusions were generated
and integrated into the chromosome of PAO1 and
PAOampR via attB-attP site-specific recombination.
These constructs are likely to mimic the chromosomal
regulation of the ampFG and ampOP operons. In the
absence of inducer in PAO1 and PAOampR, there was
a detectable basal level of promoter activity (Figure 7).
The expression of the PampOP-lacZ promoter fusion was
significantly increased in the presence of inducer in the
wild-type PAO1, and this induction was lost completely
in PAOampR (Figure 7). However, the activity of the
PampFG-lacZ promoter fusion was comparable to the
basal level in the absence and presence of inducer in
PAO1 and PAOampR.
Autoregulation of the ampG and ampP genes
To determine if ampG or ampP affected their own or
each other’s expression, PampFG-lacZ and PampOP-lacZ
promoter fusions were introduced into the chromo-
somes of PAOampP and PAOampG. Interestingly, the
activity of the PampOP-lacZ promoter fusion was signifi-
cantly de-repressed in PAOampP in the absence and
presence of inducer (Figure 7). The activity of the
PampFG-lacZ was unchanged in PAOampG in either the
absence or presence of benzyl-penicillin. Interestingly,
PampFG-lacZ activity was significantly increased in the
presence, but not absence of b-lactam in the PAOampP
mutant, suggesting b-lactam-dependent repression of
PampG by ampP. No change of the promoter activity of
the ampOP operon was observed in the PAOampG
mutant.
Discussion
Members of the Pseudomonadaceae family are intrinsi-
cally resistant to b-lactam antibiotics. Earlier reports
Figure 5 Relative b-lactamase activity in PAOampP and
PAOampG mutants. Assays were performed on the parental PAO1,
and the mutants, PAOampP and PAOampG in the presence of
benzyl-penicillin at a concentration gradient of 0 to 125 μg/ml.
Cultures at OD600 of 0.6-0.8 were induced for three hours before
harvesting. Assays were performed on sonicated lysate using
nitrocefin as a chromogenic substrate. The b-lactamase activity of
PAO1 at 100 μg/ml of benzyl-penicillin was taken as 100%. Each
value is the mean of at least three independent experiments. The
asterisk refers to p-values of < 0.05 with respect to PAO1, which
were calculated using the two-tailed Student’s t-test.
Figure 6 Activity of the ampC promoter. Promoter activity of the
ampC gene was analyzed using lacZ transcriptional fusions
integrated at the att locus of PAO1, PAOampR, PAOampG and
PAOampP (see Materials and Methods and text for details). Cells
were grown to an OD600 of 0.6 - 0.8, at which time cultures were
divided into two and one set treated with 100 μg/ml benzyl-
penicillin. After three hours, cells were harvested and b-
galactosidase activity assayed as described [10]. Each value is the
mean of at least three independent experiments.
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successfully identified ampC, ampR, ampD, and ampE
as genes involved in the b-lactamase induction mechan-
ism. However, the question of how chromosomal b-lac-
tamase is induced remains elusive. This study examines
the role of two previously uncharacterized P. aeruginosa
putative permeases.
P. aeruginosa harbors two distinct and independent
AmpG orthologues
In Enterobacteriaceae, besides AmpR, AmpD and
AmpE, AmpG has also been implicated in the ampC-
encoded b-lactamase induction, acting as a membrane
permease that transports 1,6-anhMurNAc-tripeptide and
1,6-anhMurNAc-pentapeptide [17]. In P. aeruginosa,
two paralogs, PA4393/ampG and PA4218/ampP, were
found (Figure 1) [28]. Both ampG and ampP appear to
be one member of two independent two-gene operons
(Figures 2 and 3). PFAM analysis of AmpP identifies a
Major Facilitator Superfamily (MFS1) domain between
amino acids 14 and 346, in agreement with a role in
transport [23,29,30]. Upstream from ampP is PA4219/
ampO, a gene that has seven putative transmembrane
domains [23,31]. Together, these genes form an operon
Table 2 MICs in PAO1, PAOampG and PAOampP strains
Strain MIC (μg/ml)
Amoxicillin Imipenem
PAO1 > 256 3
PAOampG 16 0.38
PAOampP > 256 3
Figure 7 Activity of the ampG and ampP promoters. Promoter activity of the ampG and ampP genes was analyzed using lacZ transcriptional
fusions integrated at the att locus of PAO1, PAOampR, PAOampG and PAOampP (see Materials and Methods and text for details). Cells were
grown to an OD600 of 0.6 - 0.8, at which time cultures were divided into two and one set treated with 100 μg/ml benzyl-penicillin. After three
hours, cells were harvested and b-galactosidase activity assayed as described [10]. All 16 conditions were assayed at the same time but are
divided into two panels for visualization purposes. Each value is the mean of at least three independent experiments. The asterisk refers to p-
values < 0.05, which were calculated using the two tailed Student’s t-test.
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(Figure 3) that is conserved in P. aeruginosa PA14, LES,
PACS2, and PA2192 [23,32]. In contrast, PFAM analysis
of AmpG does not reveal any significant hits, however,
there was an insignificant match to the MFS1 domain
(E = .00018) [29,30]. The ampG gene is downstream
from PA4392/ampF, which encodes a protein with a
putative 6-O-methylguanine-DNA methyltransferase
domain [23,33]. These two genes also form an operon
(Figure 3) that is conserved in P. aeruginosa PA14, LES,
and PA7 [23].
The topology of the E. coli AmpG permease has been
analyzed using b-lactamase fusion proteins [15]. It was
shown that AmpG has ten transmembrane domains
with the amino- and carboxyl-termini localized to the
cytoplasm [15]. In accordance with roles as transporters,
AmpG and AmpP have 14 or 16 (depending upon the
algorithm used) and 10, respectively predicted TM
domains. PhoA and LacZ fusion analysis corroborates
the existence of 14 and 10 TM domains in AmpG and
AmpP, respectively (Figure 4). In AmpG, the predicted
transmembrane helices between amino acids 440 and
460 and either 525 and 545 or 555 to 575 of PA4393
are likely false positives. AmpG fusions at amino acids
438, 468 and 495 indicate that these amino acids are
cytoplasmic (Figure 4), suggesting that if the region
between amino acids 440 and 460 is membrane asso-
ciated, it may be an integral monotopic domain. Simi-
larly, AmpG fusions at residues 495 and 594 are
cytoplasmic, while that at 540 is periplasmic, suggesting
that if the region between amino acids 525 and 545 is
membrane associated, it may be an integral monotopic
domain. The fusion data indicates that the carboxyl-ter-
mini of both AmpG and AmpP are cytoplasmic (Figure
4). Bioinformatic analysis predicts that the amino ter-
mini of both proteins are also cytoplasmic. Thus, like
E. coli AmpG, both the amino and carboxyl termini
would be cytoplasmic [15] (Figure 4).
Consistent with a role in transport, AmpP has an MFS
domain [23,30]. The Major Facilitator Superfamily
domain is present in approximately one-fourth of all
known prokaryotic transport proteins [34]. Interestingly,
most MFS proteins have 12 TM domains, while AmpP,
like E. coli AmpG, has only 10 [35]. The topology analy-
sis suggests PAO1 AmpG has 14 TM domains. PAO1
AmpG also has an insignificant MFS1 domain. A few
MFS proteins have also been shown to have 14 TM
domains [29,35].
The ampG and ampP genes are essential for maximum
b-lactamase induction
Because of the similarity between AmpG from Entero-
bacteriaceae and PAO1 AmpG and AmpP, b-lacta-
mase levels of single ampG and ampP mutant isogenic
strains were determined. Although an increase in
b-lactamase activity was observed, neither the ampG
nor ampP mutant strain produced the same level of
b-lactamase in the presence of benzyl-penicillin as
PAO1 (Table 1, Figure 5). Moreover, inactivation of
ampG or ampP abolishes induction of PampC(Figure 6).
This indicates that both ampG and ampP are essential
for chromosomal b-lactamase induction. These genes
did not cross-complement or exhibit gene dosage
effects indicating that they play different roles in the
induction pathway (Table 1). These results are consis-
tent with recent data demonstrating that mutation of
ampG affects induction of b-lactamase and failure of
ampP to complement an ampG mutation [28].
Furthermore, the analysis using increasing benzyl-peni-
cillin concentrations, shows that ampP plays an impor-
tant role at lower inducer concentrations, whereas
ampG is crucial at higher concentrations (Figure 5).
Mutation of ampG affects PAO1 b-lactam resistance
(Table 2) [28]. Recent studies by Zhang et al., in which
deletion of ampG results in increased sensitivity to
ampicillin [28], are consistent with results presented
here (Table 2). In addition, ampG inactivation
increases imipenem sensitivity (Table 2). Loss of
ampP (also referred to as ampGh1) function did not
affect b-lactam sensitivity in either study (Table 2)
[28]. AmpP (PA4218) has previously been named FptX
due to its homology to RhtX in Sinorhizobium meliloti
2011 [36]. PA4219 does not have a S. meliloti ortholo-
gue [36]. Mutation of ampP in a P. aeruginosa CDC5
derivative that produces pyochelin but not pyoverdine,
resulted in loss of pyochelin utilization [36]. In agree-
ment with a role in pyochelin utilization, ampP is
located next to genes involved in pyochelin biosynth-
esis and transport [23,36]. Thus, the results presented
in Table 1 and Figures 5 and 6 demonstrate that
ampP is involved in b-lactamase induction in addition
to its previously characterized role in pyochelin
utilization [36].
Expression of ampP is induced by b-lactam addition in
the presence of ampR
Despite the importance of ampG in b-lactamase induc-
tion, little is known about its regulation. E. coli ampG is
also the second gene in a two gene operon. Upstream
and divergently transcribed from the E. coli ampG
operon, is the bolA transcriptional regulator [24].
Expression of bolA is dependent upon RpoS. Previous
studies suggest the expression of the E. coli ampG gene
is independent of bolA, rpoS or ampD [24]. Neither the
P. aeruginosa ampG nor ampP gene is located near the
bolA locus [23], thus PampFG and PampOP -lacZ tran-
scriptional fusions were integrated into the chromosome
of isogenic PAO1 strains to begin to understand ampG
and ampP regulation.
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In light of the requirement of ampG and ampP for
maximum P. aeruginosa b-lactamase induction, it was
of interest to determine if expression of either was
affected by b-lactam addition (Table 1, Figure 5). In the
absence of antibiotic, PampFG and PampOP were constitu-
tively expressed. Expression of PampOP significantly
increased in the presence of inducer, while PampFG did
not (Figure 7).
The LysR type transcriptional regulator AmpR induces
the expression of the AmpC b-lactamase in the presence
of b-lactam antibiotics [27]. AmpR also affects the regu-
lation of additional genes involved in P. aeruginosa anti-
biotic resistance and virulence [10]. Insertional
inactivation of ampR, did not affect PampFG - lacZ activ-
ity, however, the increase in PampOP-lacZ activity pre-
viously observed upon b-lactam addition was lost in the
absence of ampR (Figure 7). This indicates that ampP
expression is regulated by AmpR. Future analyses will
determine if this regulation is direct or indirect.
ampP affects regulation of both its own promoter and
that of ampG
Given that both ampG and ampP are required for
maximum b-lactamase expression, both contain struc-
tural elements consistent with roles in transport, and
the regulation of ampP expression by b-lactam and
ampR, it was feasible that ampP could contribute to its
own expression, perhaps by transporting potential
effector molecules for AmpR. Indeed, ampP does
appear to inhibit its own expression, as PampOP activity
increased ten-fold in PAOampP in the absence, and
approximately seven-fold in the presence of b-lactam
(Figure 7). Insertional inactivation of ampP also
resulted in increased expression of PampFG in the
presence of b-lactam (Figure 7).
Proposed model for regulation of b-lactamase induction
The results presented contribute to what is known
concerning b-lactamase induction in P. aeruginosa. It
is well established that induction of the expression of
the AmpC b-lactamase is dependent upon AmpR.
Although the exact mechanism has not been well char-
acterized in P. aeruginosa, it is believed that the induc-
tion is triggered by conversion of AmpR from a
repressor to an activator (Figure 8). Evidence from
Enterobacteriaceae suggest that this is a result of inhi-
bition of the cell wall remodeling process by b-lactam
antibiotics and subsequent accumulation of intermedi-
ates which in turn serve as effector molecules for
AmpR. Consistent with previous findings suggesting
that AmpR acts as a positive regulator of amp genes
[10], activation of ampP expression required the pre-
sence of AmpR and b-lactam antibiotic (Figure 7).
Based upon glycopeptide accumulation studies in other
organisms, these findings suggest that the accumula-
tion of 1,6-anhMurNAc-tripeptide and 1,6-anhMur-
NAc-pentapeptide in the presence of b-lactam
antibiotics activates AmpR that in turn up-regulates
the expression of ampP. However, P. aeruginosa
appears to use two non-redundant permeases in b-lac-
tamase induction, suggesting, one may be involved in
the import of muramyl peptides and the other in an as
yet unknown function. The second permease may be
involved in export of muramyl peptides or import of
different muramyl peptides. Further studies to deter-
mine the identity of these peptides and how they regu-
late AmpR will be a critical next step in deciphering b-
lactam resistance in P. aeruginosa.
The ampP gene is also auto-regulated via an unknown
mechanism. If AmpP performs a similar function as
E. coli AmpG, the absence of ampP would result in the
accumulation of the periplasmic pool of GlcNAc-
anhMurNAc peptides or the reduction in the cytoplasmic
pool of 1,6-anhMurNAc-tripeptide and 1,6-anhMurNAc-
pentapeptide alerting the cell that the peptidoglycan recy-
cling process is inhibited. This signalling could result in a
positive feedback mechanism that up-regulates the
expression of ampP. The accumulation of the periplasmic
pool of 1,6-anhMurNAc-tripeptide and 1,6-anhMurNAc-
pentapeptide in PAOampP is also likely to up-regulate
the expression of P. aeruginosa PAO1 ampG in the
presence of b-lactam.
Currently, it is not known if PAO1 AmpG and AmpP
function similarly to E. coli AmpG, however, like ampG,
the PAO1 ampG and ampP are important for b-lacta-
mase induction [14] (Figure 5, Figure 6, Table 1). More-
over, ampG and ampP are not functionally redundant as
both are required for maximum induction. Their expres-
sion is also differentially regulated. An ampP promoter-
lacZ fusion exhibited increased activity in the presence
of ampR and b-lactam or the absence of ampP. An
ampG promoter-lacZ fusion was unaffected by the
absence or presence of ampR or ampG. Increased
b-galactosidase activity was observed from the ampG
promoter fusion in the presence of b-lactam in an
ampP mutant (Figure 7). It is not known if this is
dependent upon ampR, related to an ampR-independent
function of ampP in b-lactamase induction or the func-
tion of ampP in pyochelin utilization.
Conclusions
P. aeruginosa appears to have two ampG paralogs,
ampG and ampP, which encode proteins with 14 and 10
transmembrane domains. Both are required for maxi-
mum induction of chromosomal b-lactamase and induc-
tion of the ampC promoter. Expression of ampP did not
restore maximum b-lactamase induced activity in an
ampG mutation nor did expression of ampG
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complement an ampP mutation, indicating that ampG
and ampP have distinct functions in b-lactamase regula-
tion. In addition to being autoregulated, ampP is regu-
lated by AmpR and b-lactam. ampP is also involved in
the regulation of ampG in the presence of b-lactam. In
summary, the presence of two distinct permeases
required for b-lactamase induction suggests that the P.
aeruginosa b-lactamase resistance mechanism is more
complex and distinct from the current paradigm.
Methods
Bacterial strains, plasmids and media
Bacterial strains, plasmids and primers employed in this
study are shown in Table 3. E. coli and P. aeruginosa
were routinely cultured in Luria-Bertani medium (10 g
tryptone, 5 g yeast extract, 5 g NaCl, per liter). Pseudo-
monas Isolation Agar (PIA, Difco) was used in
triparental mating experiments. Mueller-Hinton agar
(Difco) was used in E-test experiments. Antibiotics,
when used, were at the following concentrations (per
liter) unless indicated otherwise: ampicillin (Ap) at
50 mg, tetracycline (Tc) at 20 mg, gentamycin (Gm) at
30 mg for E. coli and carbenicillin (Cb) at 300 mg, Gm
at 300 mg and Tc at 60 mg for P. aeruginosa.
DNA manipulations
Standard procedures in molecular biology were
performed as previously described [37].
Insertional inactivation of the ampG and ampP genes
A 2904-bp ampG fragment was PCR-amplified from
PAO1 genomic DNA using KKF01ampGFor and
KKF04ampGRev (Table 3). Similarly, KKF05ampPFor
and KKF08ampPRev were used to PCR-amplify a
Figure 8 Model for regulation of AmpC b-lactamase induction by AmpR, AmpP and AmpG in P. aeruginosa. In Enterobacteriaceae as
well as P. aerugniosa, the induction of b-lactamase expression is due to the action of the LysR transcriptional regulator, AmpR. In vitro studies
suggest that AmpR can act as either a repressor or an activator, depending upon the presence of different peptidoglycan remodelling
intermediates. In this study, it is shown that unlike previously characterized systems, P. aeruginosa has two putative AmpG permease paralogs,
AmpG and AmpP. Expression of AmpP is inducible by b-lactam in an ampR-dependent manner. The ampP gene also appears to repress its own
expression independent of b-lactam through an unknown mechanism. Although not observed to be induced by b-lactam in a PAO1
background, expression of ampG also appears to be repressed by ampP in the presence of b-lactam (see text for details).
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Table 3 Bacterial strains, plasmids and primers used in this study
Strains/Plasmids Genotype Reference
Escherichia coli
TOP10F’ F’ {lacIq, Tn10(TetR)} mcrA Δ(mrr-hsdRMS-mcrBC) f80dlacZDM15 ΔlacX74 deoR recA1 araD139 Δ(ara-leu) 7697
galU galK rpsL (StrR) endA1 nupG
Invitrogen
Pseudomonas aeruginosa
PAO1 Wild-type [47]
PKM400 PAOampP::aacCI; GmR This study
PKM500 PAOampG::aacCI; GmR This study
PKM300 PAOampR::aacCI; GmR [10]
PKM301 PAOattB::PampC-lacZ; Tc
R [10]
PKM303 PAOampR::aacCI attB::PampC-lacZ; Tc
RGmR [10]
PKM104 PAOattB::PampP-lacZ; Tc
R KKF0290, This
study
PKM105 PAOattB::PampG-lacZ; Tc
R This study
PKM312 PAOampR::aacCI attB::PampG-lacZ; Tc
RGmR This study
PKM313 PAOampR::aacCI attB::PampP-lacZ; Tc
RGmR This study
PKM404 PAOampP::aacCI attB::PampP-lacZ; Tc
RGmR This study
PKM405 PAOampP::aacCI attB::PampG-lacZ; Tc
RGmR This study
PKM504 PAOampG::aacCI attB::PampP-lacZ; Tc
RGmR This study
PKM505 PAOampG::aacCI attB::PampG-lacZ; Tc
RGmR This study
PKM506 PAOampG::aaCI attB::PampC-lacZ; Tc
RGmR This study
PKM507 PAOampP::aaCI attB::PampC-lacZ; Tc
RGmR This study
Plasmids
pCRII-TOPO ApR, KmR; ColE1ori lacZa Invitrogen
pUCGm ApR, GmR; pUC19 derivative containing gentamycin cassette [38]
pEX100T ApR; sacB oriT [39]
pMF54 ColE1-SF broad-host replicon [48]
pME6030 TcR; oriVpVS1 oriVp15A oriT [41]
pRK2013 KmR; ColE1ori-Tra (RK2)+ [40]
pTrcphoA ApR; low-copy trc promoter expression vector carrying the lacIq and phoA [43]
pTrclacZ ApR, low-copy trc promoter expression vector carrying the lacIq and lacZ [43]
pSJ10 TcR; CTX-lacZ fused with ampC promoter, PampC [10]
pKKF003 ApR, KmR; pCRII-TOPO with a 2904-bp fragment containing PAO1 coordinates 4921591-4924494 (PA4392-
PA4393/ampF-ampG)
This study
pKKF004 ApR, KmR; pCRII-TOPO with a 2779-bp fragment containing PAO1 coordinates 4721496-4724275 (PA4217-
PA4218/ampO-ampP)
This study
pKKF069 TcR; pME6030 with a 2904-bp EcoRI flanked fragment containing ampF-ampG This study
pKKF073 TcR; pME6030 with a 2779-bp EcoRI flanked fragment containing ampO-ampP This study
pKKF087 TcR; CTX-lacZ fused with ampP promoter, PampP This study
pKKF091 TcR; CTX-lacZ fused with ampG promoter, PampG This study
pKKF145 ApR, GmR; pCRII-TOPO derivative with ampP::aacCI This study
pKKF149 ApR, GmR; pCRII-TOPO derivative with ampG::aacCI This study
pKKF157 ApR, GmR; pEX100T derivative with ampG::aacCI This study
pKKF161 ApR, GmR; pEX100T derivative with ampP::aacCI This study
pAA0115 ApR, pTrcphoA with 1.9 kb PstI DNA from pMF54 containing stabilization fragment This study
pAA0112 ApR, KmR; pCRII-TOPO containing a 1797 ampG PCR product amplified using primers KKF09 and KKF10 This study
pAA0121 ApR, pAA0115 containing a 1,813 EcoRI fragment containing ampG from pAA0112 This study
pAA1261 ApR; pAA0121 digested with BamHI and SalI, treated with Klenow and re-ligated to remove an XbaI site.
Used as basis for Erase-a-base system
This study
pKKF259 ApR; pTrcphoA derivative with a 1797-bp fragment containing PA4393 This study
pKKF458 ApR; pTrcphoA derivative with a 1245-bp fragment containing PA4218 This study
pKKF459 ApR; pTrclacZ derivative with a 1797-bp fragment containing PA4393 This study
pKKF465 ApR; pTrclacZ derivative with a 1245-bp fragment containing PA4218 This study
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2779-bp ampP fragment. The ampP and ampG PCR
products were cloned into pCRII-TOPO according to
the manufacturer’s instruction (Invitrogen, CA), generat-
ing pKKF04 and pKKF03, respectively. A Gm cassette
carrying the aacCI gene was retrieved from pUCGm
[38]. The cassette was inserted into the unique HincII
and AscI restriction sites of ampP and ampG, respec-
tively, creating pKKF145 and pKKF149 (Figure 2). These
insertions created a polar mutation in the 5’-ends of
ampP and ampG ORFs in pKKF04 and pKKF03, respec-
tively. Subsequently, the ampP::aacCI and ampG::aacCI
from pKKF145 and pKKF149, respectively, were sub-
cloned into the SmaI site of pEX100T [39], a mobiliz-
able suicide plasmid. These plasmids were conjugated
into P. aeruginosa PAO1, with a helper strain harboring
pRK2013 [40]. The merodiploids, resulting from homo-
logous recombination, were selected with PIA contain-
ing Gm. These GmR colonies were then screened for
Gm resistance and Cb sensitivity by replica plating. The
insertions were confirmed by PCR and restriction analy-
sis of the PCR product (data not shown). The PAO1
isogenic strains with defective ampP and ampG are hen-
ceforth referred to as PAOampP and PAOampG,
respectively.
Construction of ampP and ampG complementing
plasmids
Plasmids containing ampP and ampG, pKKF73 and
pKKF69, respectively, were generated by inserting the
EcoRI fragment with ampP and ampG from pKKF004
and pKKF003 into a broad-host range, low copy number
vector, pME6030 [41]. These were later conjugated
into PAOampP and PAOampG for complementation
analysis.
Promoter-lacZ fusion constructions
The putative promoter regions of ampG and ampP
were subcloned from pKKF003 and pKKF004 into
pGEMEX-1, respectively, generating pKKF091 (PampFG-
lacZ) and pKKF087 (PampOP-lacZ) (Table 3). This sui-
cide vector contained the integration-proficient attP
site, which recombines into the chromosomal attB site
to generate a single-copy reporter fusion [42]. The
resulting clones were mobilized into PAO1 and
PAOampR (Table 3). The presence of the chromoso-
mal insertions was confirmed by PCR and restriction
analysis of the product.
Topological analysis of AmpP and AmpG
The topology of AmpP and AmpG were investigated
using two markers, phoA and lacZ, that function in the
periplasm and cytoplasm, respectively. The entire ampP
gene was PCR amplified using primers KKF13ampP2For
and KKF14ampP2Rev and cloned into pTrcphoA [43].
The entire ampG gene was PCR amplified using primers
KKF09ampG2For and KKF10ampG2Rev and cloned
into a pTrcphoA plasmid which had been modified by
insertion of a broad host range stabilization fragment
from pMF54 (Table 3). Both ampG and ampP genes
were cloned into pTrclacZ [43]. The erase-a-base system
(Promega, WI) was used to generate deletions of the
genes from the 3’-ends. The resulting clones were then
sequenced to determine the fusion junctions. The phoA
and lacZ activities were determined as previously
described [44].
b-lactamase and b-galactosidase assays
b-lactamase and b-galactosidase activities were assayed
as previously described [9,10].
Table 3 Bacterial strains, plasmids and primers used in this study (Continued)
Primers
KKF01ampGFor 5’-TCCAGCTTGACGTCGAGATT-3’ This study
KKF04ampGRev 5’-AGAACATTCTCCTGGCCATGG-3’ This study
KKF05ampPFor 5’-AACGGCCACGCTAGCAACAC-3’ This study
KKF08ampPRev 5’-GTGGCGCCTGGAGTCTTG-3’ This study
KKF09ampG2For 5’-GGGAATTCCATATGACTCAGCAATCCTGG-3’ This study
KKF10ampG2Rev 5’-GCTCTAGATGCTCGGCGTTCTGGTGT-3’ This study
KKF13ampP2For 5’-TCTAGATCAGGCCTCTTCCGCCCG-3’ This study
KKF14ampP2Rev 5’-ATGCTTGAGCTGTACCGCCA-3’ This study
PA4218_9junctionRTF 5’-ACCTCACCCTGATCCTCTG-3’ This study
PA4218_9junctionRTR 5’-CAGGTAGAGCAACGCCAG-3’ This study
PA4392_3junctionRTF 5’-CAACGACAGGGTGGACATAC-3’ This study
PA4392_3junctionRTR 5’-GAGACTTGTAGGCGACCAG-3’ This study
(NS)5RandomPrimer 5’-NSNSNSNSNS-3’ [49]
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Determination of minimal inhibitory concentrations
(MICs)
MICs were determined using E-test strips (Biomerieux,
Marcy l’Etoile, France) according to the manufacturer
protocols.
Reverse transcription PCR
For the reverse transcription PCR, RNA was isolated
from PAO1 using the RNAeasy mini kit (Qiagen, Valen-
cia, CA) according to the manufacturer protocol. DNA
was removed by two sequential 1 hour treatments at
37°C with RQ DNaseI (Promega Corporation, Madison,
WI) followed by heat inactivation at 65°C for 10 min-
utes. Synthesis of cDNA was performed with Superscript
III reverse transcriptase (RT) (Invitrogen, Carlsbad, CA)
using a (NS)5 random primer and 5 μg RNA according
to the manufacturer protocol. A control reaction con-
taining all components except for Superscript III RT
was performed in parallel. After cDNA synthesis, RNA
was removed by treatment with 0.2 N NaOH for 30 min-
utes at 65°C. The reactions were neutralized by addition
of 0.2 N HCl and cDNA was purified using the QIA-
quick PCR purification kit (Qiagen, Valencia, CA)
according to the manufacturer protocol.
PCR reactions to amplify the ampF-ampG intergenic
region were performed using primers PA4392_3junc-
tionRTF and PA4392_3junctionRTR (Table 3) using
GoTaq Flexi (Promega Corporation, Madison, WI). PCR
reactions to amplify the ampO-ampP overlapping region
were similarly performed with the exception that primers
PA4218_9junctionRTF and PA4218_9junctionRTR
(Table 3) were used. PCR products were analyzed by elec-
trophoresis on a 10% polyacrylamide/1× TBE gel followed
by staining with SybrSafe (Invitrogen, Carlsbad, CA).
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